Peptomyc is a company focused on the development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research on Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.
Looking for a particular Peptomyc employee's phone or email?
The Peptomyc annual revenue was $6.8 million in 2026.
Jesús Martin Garcia is the CEO of Peptomyc.
16 people are employed at Peptomyc.
Peptomyc is based in Barcelona, Catalonia.
The NAICS codes for Peptomyc are [5417, 541, 54171, 54, 541713].
The SIC codes for Peptomyc are [873, 87].